Literature DB >> 10967953

Schizophrenia epigenesis?

J S Robert1.   

Abstract

I begin by examining how genetics drives schizophrenia research, and raise both familiar and relatively novel criticisms of the evidence putatively supporting the genetic basis of schizophrenia. In particular, I call attention to a set of concerns about the effects of placentation on concordance rates of schizophrenia in monozygotic twins, which further weakens the case for schizophrenia's so-called strong genetic component. I then underscore two critical points. First, I emphasize the importance of taking seriously considerations about the complexity of both ontogenesis and the development of hereditary diseases. The recognition of developmental constraints and supports is crucial, for attention to development exposes the naivete of too many models of gene action in the aetiology of disease. Secondly, I attend to those schizophreniologists who ignore methodological criticisms and thus presume a genetic basis for schizophrenia, and then seek the 'schizophrenic genotype' lacking an adequate phenotype. In response I attempt to demonstrate the necessity of a sustained effort at characterizing the phenotype of schizophrenia as an enabling condition for the whole enterprise of psychiatric genetics--and for psychiatry itself. Without the organism-level phenotype, research at the level of genes will remain unproductive--assuming of course that research at the genetic level is appropriate at all.

Entities:  

Mesh:

Year:  2000        PMID: 10967953     DOI: 10.1023/a:1009913618140

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  49 in total

1.  Induction and the origins of developmental genetics.

Authors:  S F Gilbert
Journal:  Dev Biol (N Y 1985)       Date:  1991

2.  The evolving concept of schizophrenia: from Kraepelin to the present and future.

Authors:  N C Andreasen
Journal:  Schizophr Res       Date:  1997-12-19       Impact factor: 4.939

Review 3.  Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms.

Authors:  N C Andreasen; P Nopoulos; D S O'Leary; D D Miller; T Wassink; M Flaum
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

4.  Annotation: the analysis of variance and the analysis of causes.

Authors:  R C Lewontin
Journal:  Am J Hum Genet       Date:  1974-05       Impact factor: 11.025

5.  The diagnosis of schizophrenia.

Authors:  N C Andreasen
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

6.  Clinical phenomenology.

Authors:  N C Andreasen; D Shore; J D Burke; W M Grove; J A Lieberman; T F Oltmanns; J W Pettegrew; A E Pulver; L J Siever; M T Tsuang
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

7.  Genetics, epidemiology, and the search for causes of schizophrenia.

Authors:  M T Tsuang
Journal:  Am J Psychiatry       Date:  1994-01       Impact factor: 18.112

8.  Association between prenatal exposure to poliovirus infection and adult schizophrenia.

Authors:  J Suvisaari; J Haukka; A Tanskanen; T Hovi; J Lönnqvist
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

Review 9.  Diagnosis and classification of schizophrenia.

Authors:  N C Andreasen; W T Carpenter
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

10.  Schizophrenia in the National Academy of Sciences-National Research Council Twin Registry: a 16-year update.

Authors:  K S Kendler; C D Robinette
Journal:  Am J Psychiatry       Date:  1983-12       Impact factor: 18.112

View more
  2 in total

Review 1.  Cultural neuroscience and psychopathology: prospects for cultural psychiatry.

Authors:  Suparna Choudhury; Laurence J Kirmayer
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

2.  Environmental factors influence language development in children with autism spectrum disorders.

Authors:  Marine Grandgeorge; Martine Hausberger; Sylvie Tordjman; Michel Deleau; Alain Lazartigues; Eric Lemonnier
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.